dimethyl fumarate neuraxpharm
laboratorios lesvi s.l. - dímetýl fúmarat - heila-og mænusigg, köstum tilkynnt - Ónæmisbælandi lyf - dimethyl fumarate neuraxpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.
vildagliptin / metformin hydrochloride accord
accord healthcare s.l.u. - metformin hydrochloride, vildagliptin - sykursýki, tegund 2 - lyf notuð við sykursýki - vildagliptin/metformin hydrochloride accord is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:- in patients who are inadequately controlled with metformin hydrochloride alone. - in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. - in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 og 5. 1 fyrir tiltæk gögn um mismunandi samsetningar).
abstral tungurótartafla 800 míkróg
kyowa kirin holdings b.v. - fentanylum cítrat - tungurótartafla - 800 míkróg
abstral tungurótartafla 600 míkróg
kyowa kirin holdings b.v. - fentanylum cítrat - tungurótartafla - 600 míkróg
abstral tungurótartafla 400 míkróg
kyowa kirin holdings b.v. - fentanylum cítrat - tungurótartafla - 400 míkróg
abstral tungurótartafla 300 míkróg
kyowa kirin holdings b.v. - fentanylum cítrat - tungurótartafla - 300 míkróg
abstral tungurótartafla 200 míkróg
kyowa kirin holdings b.v. - fentanylum cítrat - tungurótartafla - 200 míkróg
abstral tungurótartafla 100 míkróg
kyowa kirin holdings b.v. - fentanylum cítrat - tungurótartafla - 100 míkróg
flúoróúracil accord stungulyf/innrennslislyf, lausn 50 mg/ml
accord healthcare b.v. - fluorouracilum inn - stungulyf/innrennslislyf, lausn - 50 mg/ml
lymecycline actavis hart hylki 300 mg
actavis group ptc ehf. - lymecyclinum inn - hart hylki - 300 mg